Potassium bicarbonate
- Generic Name
- Potassium bicarbonate
- Brand Names
- Effer-K, Sibnayal
- Drug Type
- Small Molecule
- Chemical Formula
- CHKO3
- CAS Number
- 298-14-6
- Unique Ingredient Identifier
- HM5Z15LEBN
Overview
Potassium bicarbonate is a white, crystalline, slightly alkaline and salty substance. It is produced by the passage of carbon dioxide through an aqueous potassium carbonate solution. It is used in medicine as an antacid. It is registered in the FDA under the section of suitable, safe and effective ingredients for OTC antacids. This FDA denomination classifies potassium bicarbonate as a GRAS ingredient.
Background
Potassium bicarbonate is a white, crystalline, slightly alkaline and salty substance. It is produced by the passage of carbon dioxide through an aqueous potassium carbonate solution. It is used in medicine as an antacid. It is registered in the FDA under the section of suitable, safe and effective ingredients for OTC antacids. This FDA denomination classifies potassium bicarbonate as a GRAS ingredient.
Indication
Potassium bicarbonate is used as an antacid, electrolyte replenisher and potassium supplement. It can also be used as an excipient in drug formulations. An antacid is a medication used to neutralize gastric acid in a short timeframe after ingestion and the effect is soon overcome by meal-stimulated acid secretion.
Associated Conditions
- Arrhythmias Cardiac caused by Hypokalemia
- Gastro-esophageal Reflux Disease (GERD)
- Hypocitraturia
- Hypokalemia
- Ketoacidosis caused by Hypokalemia
- Kidney Stones
- Neuromuscular Disorders caused by Hypokalemia
- Uric Acid Stones
- Calcium oxalate calculi Renal Calculi
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2020/12/03 | Early Phase 1 | Not yet recruiting |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|---|---|---|---|---|
ORAL | 391 mg in 1 1 | 2019/12/19 | 51801-013 | ||
ORAL | 782 mg in 1 1 | 2019/12/19 | 51801-012 | ||
ORAL | 391 mg in 1 1 | 2019/12/19 | 51801-014 | ||
ORAL | 25 meq in 1 1 | 2010/10/08 | 50201-2400 | ||
ORAL | 782 mg in 1 1 | 2019/12/19 | 51801-011 | ||
ORAL | 25 meq in 1 1 | 2012/04/20 | 0603-4170 | ||
ORAL | 978 mg in 1 1 | 2020/06/30 | 0245-5326 | ||
ORAL | 977.5 mg in 1 1 | 2019/12/23 | 51801-006 | ||
ORAL | 977.5 mg in 1 1 | 2019/12/23 | 51801-007 | ||
ORAL | 977.5 mg in 1 1 | 2019/12/23 | 51801-005 |
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|---|---|---|---|---|---|---|---|
EMEA/H/C/005407 | France | N/A | Authorised | 2021/04/30 | 2020/12/10 | 3 |
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|---|---|---|---|---|
SUSPENSION | 200 MG/10ML | 2020/11/17 | SIN16042P | ||
SUSPENSION | 200 mg/10 ml | 2004/12/24 | SIN12635P |
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|
No NMPA products found
No NMPA products found for this drug
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|---|---|---|---|---|
71981 | Active | 1999/12/01 | potassium bicarbonate | ||
77810 | Active | 2001/03/13 | potassium bicarbonate | ||
346341 | Active | 2020/10/21 | potassium bicarbonate |